New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies.
about
Preclinical and clinical research on inflammation after intracerebral hemorrhageHeme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhageOxidative Stress in Intracerebral Hemorrhage: Sources, Mechanisms, and Therapeutic TargetsImmune interventions in strokeMatrix metalloproteinases in human spontaneous intracerebral hemorrhage: an updateUtilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other DiseasesHeme oxygenase 2 deficiency increases brain swelling and inflammation after intracerebral hemorrhageEffects of Ranolazine on Astrocytes and Neurons in Primary CultureIntracerebral haemorrhageNew Concept of Neural Stem Cell Transplantation: Anti-inflammatory Role.Neuroprotective role of haptoglobin after intracerebral hemorrhageResveratrol protects against ICV collagenase-induced neurobehavioral and biochemical deficits.Isoflurane posttreatment reduces brain injury after an intracerebral hemorrhagic stroke in mice.Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidenceMesenchymal stem cells transplantation for neuroprotection in preterm infants with severe intraventricular hemorrhage.Systemic administration of urocortin after intracerebral hemorrhage reduces neurological deficits and neuroinflammation in rats.Mouse intracerebral hemorrhage models produce different degrees of initial and delayed damage, axonal sprouting, and recoveryAlternative activation-skewed microglia/macrophages promote hematoma resolution in experimental intracerebral hemorrhage.Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice.The development of an improved preclinical mouse model of intracerebral hemorrhage using double infusion of autologous whole bloodMolecular pathophysiology of cerebral hemorrhage: secondary brain injury.Effects of minocycline on apoptosis and angiogenesis-related protein expression in a rat model of intracerebral hemorrhage.Attenuation of hematoma size and neurological injury with curcumin following intracerebral hemorrhage in miceCleaning up after ICH: the role of Nrf2 in modulating microglia function and hematoma clearanceNLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage.Experimental intracerebral hemorrhage: avoiding pitfalls in translational research.Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury.Treatment targets in intracerebral hemorrhage.Dimethyl Fumarate Protects Brain From Damage Produced by Intracerebral Hemorrhage by Mechanism Involving Nrf2.The association between serum adhesion molecules and outcome in acute spontaneous intracerebral hemorrhage.Role of Nrf2 in protection against intracerebral hemorrhage injury in mice.Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage.Autologous Bone Marrow Mononuclear Cells Exert Broad Effects on Short- and Long-Term Biological and Functional Outcomes in Rodents with Intracerebral Hemorrhage.PPARγ-induced upregulation of CD36 enhances hematoma resolution and attenuates long-term neurological deficits after germinal matrix hemorrhage in neonatal rats.Nrf2 to pre-condition the brain against injury caused by products of hemolysis after ICH.Inflammation after intracerebral hemorrhage.Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury.Tranexamic Acid as Antifibrinolytic Agent in Non Traumatic Intracerebral Hemorrhages.Age-Dependent Effects of Haptoglobin Deletion in Neurobehavioral and Anatomical Outcomes Following Traumatic Brain Injury.Role of PGE₂ EP1 receptor in intracerebral hemorrhage-induced brain injury
P2860
Q24594191-704CF383-E6D9-46B7-B1D2-530E5D1D91AEQ24657220-5A085B92-1923-481F-80C9-EFEB80BC4903Q26769071-D0AC5D70-0EB9-4B7F-8F65-7CA75389EEBBQ26797993-45C579BB-5C1A-48B8-A918-354AD13C1D58Q27001044-AA0FFE56-D464-4C6C-90A8-D8358F8C26B1Q28078742-54D4A51C-B439-4582-93FB-D907F2434F2CQ28289527-C466FD43-46AC-4857-A741-E92A0EB77F3EQ28550579-8F8272F7-634B-484E-AB0B-C0F53FBB3547Q33442365-73DD7E39-1FFB-4177-84F5-4AB45B224A57Q33614732-B121B32E-59E1-4C1F-BEAE-97D082F87310Q33699650-777CD59E-0205-49F4-B917-1398212789F8Q33784931-DFC9A032-40A3-4055-82D2-45BAA5734186Q33906540-160D5305-D547-40AC-8043-378F12DA9829Q33947639-CBC3FA38-9499-4D4D-8F51-7E13E5E68392Q33969422-056295F7-33E8-4DFF-9A2D-2A9AB3672D52Q34132535-3C8FD02F-73C8-4BB5-87B6-F251D8F3A21EQ34153424-5B86297C-8219-4D2B-AE18-B54B55956F73Q34554517-A84B12AB-4E1D-444A-9707-3AF7EBD0D144Q34714731-C3991D50-0D6D-4D45-8347-E62514D8B309Q34789898-6C7768D9-BDCE-49B1-AB50-98D621685824Q35070264-B611B7B8-F4A1-417E-8353-1AA87E899731Q35139311-02387856-4CF6-4D46-A1F5-099082147E78Q35157144-542EC4B6-BB4A-4E29-8B83-3915C6770635Q35181594-47DD2326-42B9-4B26-9C99-5E12178D0BB5Q35282959-4784D7C1-3964-4D2A-8917-CB5EABE211A0Q35534164-7927D925-FADF-4171-85A0-7379F30EE2BCQ35577480-A0649044-2EC7-4764-A96D-370F01577B37Q35648063-229BF363-3694-472C-8812-A773C8AE9DD7Q35779056-E82B6591-1C69-473F-90D1-6D0CFBD2C673Q36073088-A8EEA8E2-DB00-4C12-86AA-647147F69F78Q36087853-62DD0E56-2909-4B86-AFBA-13E319585B16Q36269102-DA9D58C3-8B2C-4603-8279-12ABC5FF2242Q36301669-5F936797-6BA8-44A3-8309-E4C314A800EEQ36495190-A01507AC-2FEA-491B-99D1-C7F996BDB3E2Q36573668-6B7DA73B-4193-4A16-A1E3-9E1AA9983B20Q36620460-C8408781-1547-4450-B291-474D15088844Q36687238-5DEE46B5-E88F-4A23-B70A-C826D4DC36B4Q36696939-7AA2BF09-0743-4E7B-88F9-17FFDE0F679BQ37104919-E199AC25-DF55-4253-A67D-1B96A2E25936Q37209907-FB692A6F-5903-4292-B256-5FC728595421
P2860
New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
New horizons for primary intra ...... ence from preclinical studies.
@ast
New horizons for primary intra ...... ence from preclinical studies.
@en
type
label
New horizons for primary intra ...... ence from preclinical studies.
@ast
New horizons for primary intra ...... ence from preclinical studies.
@en
prefLabel
New horizons for primary intra ...... ence from preclinical studies.
@ast
New horizons for primary intra ...... ence from preclinical studies.
@en
P2860
P356
P1476
New horizons for primary intra ...... ence from preclinical studies.
@en
P2093
Christiana E Hall
Jaroslaw Aronowski
P2860
P304
P356
10.1179/016164105X25225
P577
2005-04-01T00:00:00Z